These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 27649319)
1. Recent advancements in combination subunit vaccine development. Tan M; Jiang X Hum Vaccin Immunother; 2017 Jan; 13(1):180-185. PubMed ID: 27649319 [TBL] [Abstract][Full Text] [Related]
2. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine. Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974 [TBL] [Abstract][Full Text] [Related]
3. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus. Wu Y; Zhu R; Xu L; Li Y; Li S; Yu H; Li S; Zhu H; Cheng T; Xia N Vaccine; 2017 May; 35(20):2728-2735. PubMed ID: 28408118 [TBL] [Abstract][Full Text] [Related]
4. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses. Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348 [TBL] [Abstract][Full Text] [Related]
5. Virus-like particles produced in plants as potential vaccines. Scotti N; Rybicki EP Expert Rev Vaccines; 2013 Feb; 12(2):211-24. PubMed ID: 23414411 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice. Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453 [TBL] [Abstract][Full Text] [Related]
7. Subviral particle as vaccine and vaccine platform. Tan M; Jiang X Curr Opin Virol; 2014 Jun; 6():24-33. PubMed ID: 24662314 [TBL] [Abstract][Full Text] [Related]
8. Foot-and-mouth disease vaccines: progress and problems. Cao Y; Lu Z; Liu Z Expert Rev Vaccines; 2016 Jun; 15(6):783-9. PubMed ID: 26760264 [TBL] [Abstract][Full Text] [Related]
9. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease. Lyu K; He YL; Li HY; Chen R J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity. Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499 [TBL] [Abstract][Full Text] [Related]
11. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets. Zhang H; Qian P; Peng B; Shi L; Chen H; Li X Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115 [TBL] [Abstract][Full Text] [Related]
12. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties. Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151 [TBL] [Abstract][Full Text] [Related]
13. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus. Garg H; Sedano M; Plata G; Punke EB; Joshi A J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019 [TBL] [Abstract][Full Text] [Related]
14. Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation. Shanmugam RK; Ramasamy V; Shukla R; Arora U; Swaminathan S; Khanna N Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31093663 [TBL] [Abstract][Full Text] [Related]
15. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749 [TBL] [Abstract][Full Text] [Related]
16. Establishment of a yeast-based VLP platform for antigen presentation. Wetzel D; Rolf T; Suckow M; Kranz A; Barbian A; Chan JA; Leitsch J; Weniger M; Jenzelewski V; Kouskousis B; Palmer C; Beeson JG; Schembecker G; Merz J; Piontek M Microb Cell Fact; 2018 Feb; 17(1):17. PubMed ID: 29402276 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of virus-like particles and recombinant fiber proteins in broiler-breeder vaccination against fowl adenovirus (FAdV)-8b. Gupta A; Ahmed KA; Ayalew LE; Popowich S; Kurukulasuriya S; Goonewardene K; Gunawardana T; Karunarathna R; Ojkic D; Tikoo SK; Willson P; Gomis S Vaccine; 2017 May; 35(20):2716-2722. PubMed ID: 28396209 [TBL] [Abstract][Full Text] [Related]
18. Vaccine against norovirus. Tan M; Jiang X Hum Vaccin Immunother; 2014; 10(6):1449-56. PubMed ID: 24718366 [TBL] [Abstract][Full Text] [Related]
19. Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease. Shen H; Xue C; Lv L; Wang W; Liu Q; Liu K; Chen X; Zheng J; Li X; Cao Y Virus Res; 2013 Dec; 178(2):430-6. PubMed ID: 24050994 [TBL] [Abstract][Full Text] [Related]